NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Dementia: Assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (NICE); 2018 Jun. (NICE Guideline, No. 97.)
Dementia: Assessment, management and support for people living with dementia and their carers.
Show details| Abbreviations used in this guideline | |
|---|---|
| AAS | Anticholinergic Activity Scale |
| ABC | Anticholinergic Burden Classification |
| ACE | Angiotensin converting enzyme |
| ACER | Addenbrooke’s Cognitive Exam-Revised |
| AChE | Acetyl(cholinesterase) inhibitor |
| ACL | Anticholinergic Loading Scale |
| AD | Alzheimer’s disease |
| ADAS-cog | Alzheimer’s Disease Assessment Cognitive Subscale |
| ADCS-ADL | Alzheimer’s Diseases Cooperative Study – Activities Of Daily Living |
| ADCS-CGIC | Alzheimer’s Disease Cooperative Study- Clinician’s Global Impression Of Change |
| ADL | Activities Of daily living |
| Apo E | Apolipoprotein E |
| BBS | Berg Balance Scale |
| BNT | Boston Naming Test |
| BS | Barthel Index Score |
| BTA | Brief Test Of Attention |
| CADASIL | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy |
| CAM | Confusion Assessment Method |
| CBD | Corticobasal degeneration |
| CDR | Clinical Dementia Rating Scale |
| CEMDA | Cambridge Examination for Mental Disorders In Elderly |
| CERAD | Consortium to Establish a Registry for Alzheimer’s Disease |
| CIBIC+ | Clinician’s Interview Based Impression of Change Plus Caregivers Assessment |
| CJD | Creutzfeldt-Jakob disease |
| CLP | Contrastophore-linker-pharmacophore |
| CrAS | Clinician’s Rated Anticholinergic |
| CSF | Cerebrospinal fluid |
| CT | Computed tomography |
| CTD | Cognitive Test for Delirium |
| CVLT | California Verbal Learning Test |
| DAD | Disability Assessment for Dementia |
| DAD | Disability Assessment Daily |
| DEMQOL | Dementia-Specific Quality of Life |
| DI | Delirium Index |
| D-KEFS | Delis-Kaplan Executive Functions System Verbal Fluency Test |
| DLB | Dementia With Lewy bodies |
| DNAR | Do not attempt resuscitation |
| DRS | Delirium Rating Scale |
| DSM | Diagnostic and Statistical Manual of Mental Disorders |
| EDSSS | Expanded Disability Status Scale |
| EEG | Electroencephalography |
| FAQ | Functional Activities Questionnaire |
| FBI | Frontal Behavioural Inventory |
| FDG-PET | Fluorodeoxyglucose positron emission tomography |
| FST | Faces Symbol Test |
| FTD | Frontotemporal dementia |
| GDS | Global Deterioration Scale |
| GHQ | General Health Questionnaire |
| GMC | General Medical Council |
| GPCOG | General Practitioner Assessment of Cognition |
| HAND | HIV-associated neurocognitive disorder |
| HDL | High-density lipoprotein |
| HIS | Hachinski Ischemic Scale |
| ICD-10 | International Statistical Classification of Disease and Related Health Problems |
| ICER | Incremental cost-effectiveness ratio |
| IQCODE | Informant Questionnaire on Cognitive Decline in the Elderly |
| LBCR | Lewy Body Composite Risk Score |
| MAI | Medication Appropriateness Index |
| MCI | Mild cognitive impairment |
| MDRS | Mattis Dementia Rating Scale |
| MIBG | Metaiodobenzylguanidine |
| Mini-ACE | Mini-Addenbrooke’s Cognitive Exam |
| MMSE | Mini-Mental State Examination |
| MoCA | Montreal Cognitive Assessment |
| MRI | Magnetic resonance imaging |
| MUSIC | Multiple Sclerosis Inventarium Cognition Score |
| NMB | Net monetary benefit |
| NOPPAIN | Non Communicative Patients Pain Assessment |
| NRS | Numerical Rating Scale |
| NPV | Negative predictive values |
| NSAIDs | Nonsteroidal anti-inflammatory drugs |
| NPI | Neuropsychiatric Inventory |
| OSLA | Observational Scale of Level of Arousal |
| PACSLAC | Pain Assessment Checklist for Seniors with Limited Ability to Communicate |
| PAINAD | Pain Assessment in Advanced Dementia |
| PASAT | Paced Auditory Serial Addition Test |
| PDD | Parkinson’s disease dementia |
| PET | Positron emission tomography |
| PIB | Pittsburgh compound B |
| PPA | Primary progressive aphasia |
| PPV | Positive Predictive Values |
| QALY | Quality-adjusted life-year |
| QoL | Quality of life |
| RBANS | Repeatable Battery for The Assessment of Neuropsychological Status |
| REPOS | Rotterdam Elderly Pain Observation Scale |
| RFFT | Ruff Figure & Fluency Test |
| RUDAS | Rowland Universal Dementia Assessment Scale |
| SAA | Serum Anticholinergic Activity |
| SCEAM | Sheffield Care Environment Assessment Matrix |
| SDMT | Symbol Digit Modalities Test |
| SMC | Subjective Memory Complaints |
| SMMSE | Standardised Mini-Mental State Examination |
| SPECT | Single-photon emission computed tomography |
| SPMSQ | Short Portable Mental Status Questionnaire |
| SRT | Spatial Recall Test |
| TFLS | Texas Functional Living Scale |
| TOL | Tower of London Test of Learning and Memory |
| TYM | Test Your Memory |
| UPDRS | Unified Parkinson’s Disease Rating Scale |
| WMS | Wechsler Memory Scale |
| VaD | Vascular dementia |
| ZBI | Zarit Burden Interview |
- Glossary - DementiaGlossary - Dementia
- GRADE and CERQual tables - DementiaGRADE and CERQual tables - Dementia
- galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 [Mus musculu...galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 [Mus musculus]gi|13195672|ref|NP_077218.1|Protein
- Garrulax pectoralis isolate 774 cytochrome b gene, partial cds; mitochondrialGarrulax pectoralis isolate 774 cytochrome b gene, partial cds; mitochondrialgi|2315203781|gb|MW651325.1|Nucleotide
- Garrulax pectoralis isolate 810 cytochrome b gene, partial cds; mitochondrialGarrulax pectoralis isolate 810 cytochrome b gene, partial cds; mitochondrialgi|2315203773|gb|MW651321.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...